Treatment Approach for Essential Tremor with Gait Instability
For a patient with essential tremor and gait instability, initiate propranolol (80-240 mg/day) or primidone as first-line pharmacological treatment while simultaneously addressing the gait instability through physical therapy and fall prevention strategies, avoiding medications that may worsen balance. 1
First-Line Pharmacological Management
Medication Selection
- Propranolol (80-240 mg/day) is the preferred first-line agent for essential tremor, demonstrating efficacy in up to 70% of patients with over 40 years of established use 1, 2
- Primidone is an equally effective first-line alternative, though clinical benefits may not become apparent for 2-3 months, requiring an adequate trial period 1
- Initiate treatment only when tremor interferes with function or quality of life 1
Critical Contraindications for Beta-Blockers
- Avoid propranolol in patients with:
- In elderly patients, excessive heart rate reduction may lead to serious adverse events 1
- Common adverse effects include fatigue, depression, dizziness, hypotension, and exercise intolerance 1
Alternative Beta-Blockers if Propranolol Not Tolerated
- Nadolol (40-320 mg daily) 1, 2
- Metoprolol (25-100 mg extended release daily or twice daily) 1, 2
- Timolol (20-30 mg/day) 1
Addressing Gait Instability
Key Consideration
Gait instability in essential tremor patients requires special attention as it may be exacerbated by medications, particularly beta-blockers which can cause dizziness and hypotension. 1
Management Strategy
- Implement treadmill training with partial body weight support as an adjunct to conventional therapy for patients with mild-to-moderate gait dysfunction 3
- Consider aggressive bracing and assisted walking programs 3
- Monitor for medication-induced orthostatic hypotension that could worsen gait instability 1
- Utilize rhythm modification techniques: superimpose alternative rhythms on existing tremor and gradually slow movement to complete rest 1, 2
Second-Line Treatment Options
If First-Line Agents Fail
- Combine propranolol and primidone if monotherapy provides inadequate tremor control 4, 5
- Gabapentin has limited evidence for moderate efficacy as a second-line option 1, 2
- Benzodiazepines (such as clonazepam) may provide benefit, particularly in patients with associated anxiety 4, 5
- Topiramate may be considered 4, 5
Important Primidone Considerations
- Therapeutic benefit can occur even when derived phenobarbital levels remain subtherapeutic 1
- Women of childbearing age require counseling about teratogenic risks (neural tube defects) 1
- Behavioral disturbances, irritability, and sleep disturbances can occur at higher doses 1
Surgical Interventions for Refractory Cases
Indications
Consider surgical options when medications fail due to lack of efficacy at maximum doses, dose-limiting side effects, or medical contraindications. 1
Surgical Options Hierarchy
Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy - preferred for unilateral tremor
- Shows sustained tremor improvement of 56% at 4 years 1, 2, 6
- Lowest complication rate (4.4%) compared to radiofrequency thalamotomy (11.8%) and DBS (21.1%) 1, 6
- Early adverse effects include gait disturbance (36%) and paresthesias (38%), decreasing to 9% and 14% respectively by 1 year 1
- Contraindications: bilateral treatment needed, previous contralateral thalamotomy, skull density ratio <0.40, inability to undergo MRI 1, 6
Deep Brain Stimulation (DBS) - preferred for bilateral tremor
Radiofrequency Thalamotomy - available but carries higher complication risks (11.8%) 1
Common Pitfalls to Avoid
- Do not prescribe aids and equipment in the acute phase as they may interrupt normal automatic movement patterns 1
- If aids are necessary for safety, consider them short-term solutions with a plan to progress toward independence 1
- Avoid cocontraction or tensing of muscles as a long-term strategy 1
- Do not delay adequate trial periods for primidone (2-3 months needed for full benefit assessment) 1
- Monitor carefully for medication-induced worsening of gait instability, particularly with beta-blockers causing orthostatic hypotension 1